Private Equity 24 Hours

Last updated: June 5, 2026, 11:30 PM ET

Board Moves & Founder Shifts Reid Hoffman stepped down from Microsoft’s board after a decade that saw the tech giant’s market cap triple, opting to devote full attention to Manus, his AI‑driven drug‑discovery startup. His exit underscores a broader trend of seasoned entrepreneurs re‑entering founder mode, a shift amplified this week as a viral thread on X surfaced dozens of founders recounting “VC horror stories” ranging from aggressive term‑sheet demands to post‑money valuation disputes, prompting several high‑profile investors to publicly defend their practices . The combined narrative highlights growing founder fatigue with traditional venture capital dynamics and a potential pivot toward alternative financing structures.

Mid‑Market Fundraising TJC’s Resolute Fund VII targeted $8.5bn to back North American mid‑ and upper‑mid‑market companies, reflecting private equity’s continued appetite for stable cash‑flow businesses amid uncertain public‑market conditions. Meanwhile, Nordic firm Norvestor closed its flagship at €2bn just three months after launch, raising €500m more than its predecessor and signaling strong limited‑partner confidence in European growth‑stage platforms. Both funds aim to capitalize on the “sweet spot” where enterprise values are large enough to support leverage but small enough to avoid intense competition from mega‑cap sponsors.

Strategic Acquisitions Mill Point agreed to acquire industrial‑products distributor Total Safety Supplies & Solutions, adding a portfolio of safety equipment brands that complement its existing supply‑chain assets and should generate cross‑sell opportunities in the U.S. market. In a parallel automotive carve‑out, Mutares sold Walor Precision Turning to French sponsor Reed Capital, a deal that extracts a high‑margin component manufacturer from the broader Walor Group and provides Reed with a foothold in Europe’s precision‑turning niche. Both transactions illustrate private equity’s focus on consolidating fragmented industrial sectors to drive operational efficiencies.

Consumer Credit Expansion CPP Investments expanded its forward‑flow agreement with fintech lender Affirm, committing $1.7bn for a 24‑month term and retaining an optional lift‑up to $2.2bn, a move that underpins an expected $8bn loan volume pipeline and reflects confidence in consumer‑credit demand despite rising interest rates. The enlarged commitment also aligns with CPP’s broader strategy to secure long‑term exposure to high‑growth fintech platforms that benefit from digital payment trends and regulatory tailwinds.

Public‑Market Exits & Valuations Advent International and ADIA raised $2.43bn through Innio’s Nasdaq debut, where the gas‑engine maker surged 23% on first‑day trading, delivering a premium valuation that validates the appetite for clean‑energy infrastructure assets. Similarly, Blackstone‑backed Liftoff Mobile valued at $4.18bn after a 9% pop in its Nasdaq debut, marking another successful public‑market exit for a private‑equity‑owned ad‑tech firm and reinforcing the viability of SPAC‑free listings for high‑growth digital platforms.

Asset‑Management & Biotech Deals* Allianz Global Investors neared a $467m deal to acquire UOB Asset Management, edging out competitors KKR and Amundi and signaling European asset managers’ drive to expand Asian distribution networks. In the biotech arena, Oxford Bio Medica’s CEO kept the door open for private‑equity bidders after rejecting EQT’s approach, indicating that the FTSE‑250 cell‑and‑gene therapy specialist remains amenable to a take‑private transaction if valuation and strategic fit align. These pursuits highlight private equity’s continued search for scale‑up opportunities in both financial services and frontier life‑science sectors.**

M&A Risks & Market Sentiment A recent Aon study warned of rising fraud in M&A transactions, prompting sponsors to tighten due‑diligence protocols as deal volumes rebound post‑pandemic. The same report noted Apollo’s withdrawal of a $2bn bid for heat‑treatment firm Bodycote, citing valuation gaps and heightened regulatory scrutiny. The heightened focus on transaction integrity underscores a shifting risk calculus for private‑equity firms navigating an increasingly complex deal environment.